Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou can take Wegovy at any time of day, on any day of the week — the most important thing is picking a time you can stick to, because consistency matters more than the clock. Wegovy is a once-weekly subcutaneous injection, so missing or shifting your injection day disrupts the steady level of semaglutide in your system. That said, a few practical factors make some times genuinely better than others for most people. Wegovy is a prescription-only medicine requiring clinical assessment before it can be prescribed; the guidance below reflects the published patient information and NHS guidance for semaglutide.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Not in any clinically meaningful way. Semaglutide reaches peak concentration in your blood roughly one to three days after each injection and then falls gradually over the following week. Because of that long, shallow curve, whether you inject on a Monday morning or a Monday night makes no detectable difference to how much weight you lose or how well your appetite is controlled.
What does matter is keeping roughly the same interval between doses. Inject too early or too late on a regular basis and you introduce unnecessary peaks and troughs. The NHS guidance on semaglutide is clear: pick a day of the week and a time that fits your life, then repeat it. Some people tie it to a standing appointment, the same evening they do their weekly food shop, or the morning before a regular gym session. Find the anchor that works for you.
If you want a closer look at how the day-of-week question plays out in practice, the day-of-week timing guide on the site goes into more detail on choosing and switching injection days.
This is one of those questions our prescribers hear regularly, and the honest answer is: it depends on how your body responds during the first few weeks. Nausea, which is the most common early side effect of Wegovy, tends to peak in the hours after injection and then settles. If you find nausea noticeable, injecting in the evening means much of it passes while you sleep. Many people genuinely prefer that.
On the other hand, if you experience disturbed sleep, vivid dreams or simply feel unsettled at night after injecting, a morning dose makes more sense. The side-effect profile of Wegovy is led by gastrointestinal symptoms (nausea, loose stools, constipation, indigestion) and these are typically most pronounced after a dose increase, usually easing within a week or two as your body adjusts.
There is no clinical evidence that morning dosing outperforms evening dosing or vice versa. It is a quality-of-life call. If you are still weighing up which injection time suits you, the page on taking Wegovy at night covers the evening-dose question specifically.
Life happens. If you remember a missed dose within five days of your usual injection day, you can take it then and return to your normal schedule the following week. If more than five days have passed, skip that dose entirely and continue from your next scheduled day. Never inject two doses to make up for a missed one.
Changing your regular injection day permanently is possible, but there needs to be at least 48 hours between the last dose and the new one. After that, your new chosen day becomes your regular schedule going forward. Your patient information leaflet sets out this guidance in full, and your prescriber can advise if you are unsure.
For a practical walkthrough of adjusting your weekly schedule, the guide to choosing your weekly injection time is worth a read. And if you are still in the earlier stages of deciding whether Wegovy is the right treatment for you, the Wegovy suitability page covers eligibility and the clinical considerations in plain language.
No. Oral semaglutide (the Wegovy tablet, approved by the MHRA in June 2026) has strict timing requirements that the injection does not. The tablet must be taken first thing in the morning on a completely empty stomach, with a small amount of plain water, and you must then wait at least 30 minutes before eating, drinking anything other than water, or taking other oral medicines. That 30-minute window is not negotiable, it directly affects how much semaglutide your body absorbs.
The weekly injection carries none of those food-timing restrictions. You can inject it before or after a meal, with a coffee in hand, at whatever point in your day makes sense. That flexibility is one practical advantage the injection holds over the tablet for people with busy or unpredictable mornings.
If you are curious about how the injectable and tablet forms compare for your lifestyle, the semaglutide overview covers both licensed UK formats. Pricing and treatment options are set out on the weight-loss treatments page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.